Cargando…
mTOR at the Transmitting and Receiving Ends in Tumor Immunity
Cancer is a complex disease and a leading cause of death worldwide. Immunity is critical for cancer control. Cancer cells exhibit high mutational rates and therefore altered self or neo-antigens, eliciting an immune response to promote tumor eradication. Failure to mount a proper immune response lea...
Autores principales: | Guri, Yakir, Nordmann, Thierry M., Roszik, Jason |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890199/ https://www.ncbi.nlm.nih.gov/pubmed/29662490 http://dx.doi.org/10.3389/fimmu.2018.00578 |
Ejemplares similares
-
mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment
por: Mafi, Sahar, et al.
Publicado: (2022) -
mTOR Regulation of Lymphoid Cells in Immunity to Pathogens
por: Keating, Rachael, et al.
Publicado: (2016) -
All PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells
por: Gamper, Christopher J., et al.
Publicado: (2012) -
Akt and mTOR in B Cell Activation and Differentiation
por: Limon, Jose J., et al.
Publicado: (2012) -
TOX Acts as a Tumor Suppressor by Inhibiting mTOR Signaling in Colorectal Cancer
por: Yang, Mengdi, et al.
Publicado: (2021)